INCIDENCE OF CYTOGENETIC ABNORMALITIES IN NEWLY DIAGNOSED BINET STAGE A B-CLL AND RELATIONSHIP WITH PROGNOSTIC BIO-MARKERS: UPDATED RESULTS ON 319 PATIENTS INCLUDED IN THE PROSPECTIVE O-CLL1 GISL STUDY